PJ

Paresh Jaysih Sampat

Active Director Director DIN 00410185
DIN 00410185 First appointment Jun 2001 Primary industry Consumer Goods
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 6 active board seats
Past companies 10 historical roles
Total affiliations 16 Since Jun 2001
Shareholding value β€’β€’β€’β€’ Premium profile
Directorship timeline
First appointment 01 Jun 2001
Active appointments 9
Total timeline records 16

Paresh Jaysih Sampat (DIN 00410185) has 16 recorded board appointments in Indian companies, the first from June 2001, of which 9 are current. The chart and the list below show each company, the role held and the years of the appointment, as filed with the Ministry of Corporate Affairs.

Appointment history

Since 2001
Doctrack Solutions Limited Managing Director · 2024 – present
Current
Augmentors Healthcare Limited Director · 2024 – present
Current
Aumen Healthcare Private Limited Director · 2023 – present
Current
Steckbeck Jewelry Private Limited Director · 2021 – present
Current
Chemolec Enterprises Llp Designated Partner · 2021 – present
Current
Augmentors Healthcare Llp Designated Partner · 2019 – present
Current
Emffam Endeavours Private Limited Director · 2015 – present
Current
Emffam Enterprises Private Limited Director · 2015 – present
Current
Arth Welfare Foundation Director · 2005 – present
Current
Parle Industries Limited Director · 2014 – 2020
Previous
Rasberry Media Limited Director · 2007 – 2010
Previous
Previous
Previous
Glimmer Enterprise Private Limited Director · 2005 – 2009
Previous
Hazoor Multi Projects Limited Director · 2003 – 2019
Previous
Cachet Pharmaceuticals Private Limited Company Secretary · 2001 – 2012
Previous

Interactive timeline

Hover bars for tenure details
Loading chart...
Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available